Patents by Inventor Rene St-Arnaud

Rene St-Arnaud has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cloned transmembrane receptor for 24-hydroxylated vitamin D compounds and uses thereof
    Patent number: 8663937
    Abstract: The instant invention relates to the use of 24-hydroxylated vitamin D compounds as therapeutics in mammalian bone fracture repair. In addition, the instant invention relates to novel 24-hydroxylated vitamin D compound receptors which can be employed in the development of compounds capable of facilitating fracture repair in animals. The instant invention also relates to nucleic acids encoding such receptors as well as vectors, host cells, transgenic animals comprising such nucleic acids and screening assays employing such receptors.
    Type: Grant
    Filed: May 30, 2013
    Date of Patent: March 4, 2014
    Assignee: Shriners Hospital For Children
    Inventor: Rene St-Arnaud
  • Cloned transmembrane receptor for 24-hydroxylated vitamin D compounds and uses thereof
    Patent number: 8663986
    Abstract: The instant invention relates to the use of 24-hydroxylated vitamin D compounds as therapeutics in mammalian bone fracture repair. In addition, the instant invention relates to novel 24-hydroxylated vitamin D compound receptors which can be employed in the development of compounds capable of facilitating fracture repair in animals. The instant invention also relates to nucleic acids encoding such receptors as well as vectors, host cells, transgenic animals comprising such nucleic acids and screening assays employing such receptors.
    Type: Grant
    Filed: November 29, 2011
    Date of Patent: March 4, 2014
    Assignee: Shriners Hospital For Children
    Inventor: Rene St-Arnaud
  • Cloned transmembrane receptor for 24-hydroxylated vitamin D compounds and uses thereof
    Patent number: 8663934
    Abstract: The instant invention relates to the use of 24-hydroxylated vitamin D compounds as therapeutics in mammalian bone fracture repair. In addition, the instant invention relates to novel 24-hydroxylated vitamin D compound receptors which can be employed in the development of compounds capable of facilitating fracture repair in animals. The instant invention also relates to nucleic acids encoding such receptors as well as vectors, host cells, transgenic animals comprising such nucleic acids and screening assays employing such receptors.
    Type: Grant
    Filed: May 30, 2013
    Date of Patent: March 4, 2014
    Assignee: Shriners Hospital for Children
    Inventor: Rene St-Arnaud
  • Cloned transmembrane receptor for 24-hydroxylated vitamin D compounds and uses thereof
    Patent number: 8658854
    Abstract: The instant invention relates to the use of 24-hydroxylated vitamin D compounds as therapeutics in mammalian bone fracture repair. In addition, the instant invention relates to novel 24-hydroxylated vitamin D compound receptors which can be employed in the development of compounds capable of facilitating fracture repair in animals. The instant invention also relates to nucleic acids encoding such receptors as well as vectors, host cells, transgenic animals comprising such nucleic acids and screening assays employing such receptors.
    Type: Grant
    Filed: May 30, 2013
    Date of Patent: February 25, 2014
    Assignee: Shriners Hospital For Children
    Inventor: Rene St-Arnaud
  • CLONED TRANSMEMBRANE RECEPTOR FOR 24-HYDROXYLATED VITAMIN D COMPOUNDS AND USES THEREOF
    Publication number: 20130254910
    Abstract: The instant invention relates to the use of 24-hydroxylated vitamin D compounds as therapeutics in mammalian bone fracture repair. In addition, the instant invention relates to novel 24-hydroxylated vitamin D compound receptors which can be employed in the development of compounds capable of facilitating fracture repair in animals. The instant invention also relates to nucleic acids encoding such receptors as well as vectors, host cells, transgenic animals comprising such nucleic acids and screening assays employing such receptors.
    Type: Application
    Filed: May 30, 2013
    Publication date: September 26, 2013
    Applicant: Shriners Hospital For Children
    Inventor: Rene St-Arnaud
  • CLONED TRANSMEMBRANE RECEPTOR FOR 24-HYDROXYLATED VITAMIN D COMPOUNDS AND USES THEREOF
    Publication number: 20130252250
    Abstract: The instant invention relates to the use of 24-hydroxylated vitamin D compounds as therapeutics in mammalian bone fracture repair. In addition, the instant invention relates to novel 24-hydroxylated vitamin D compound receptors which can be employed in the development of compounds capable of facilitating fracture repair in animals. The instant invention also relates to nucleic acids encoding such receptors as well as vectors, host cells, transgenic animals comprising such nucleic acids and screening assays employing such receptors.
    Type: Application
    Filed: May 30, 2013
    Publication date: September 26, 2013
    Applicant: Shriners Hospital For Children
    Inventor: Rene St-Arnaud
  • CLONED TRANSMEMBRANE RECEPTOR FOR 24-HYDROXYLATED VITAMIN D COMPOUNDS AND USES THEREOF
    Publication number: 20130252252
    Abstract: The instant invention relates to the use of 24-hydroxylated vitamin D compounds as therapeutics in mammalian bone fracture repair. In addition, the instant invention relates to novel 24-hydroxylated vitamin D compound receptors which can be employed in the development of compounds capable of facilitating fracture repair in animals. The instant invention also relates to nucleic acids encoding such receptors as well as vectors, host cells, transgenic animals comprising such nucleic acids and screening assays employing such receptors.
    Type: Application
    Filed: May 30, 2013
    Publication date: September 26, 2013
    Applicant: Shriners Hospital For Children
    Inventor: Rene St-Arnaud
  • CLONED TRANSMEMBRANE RECEPTOR FOR 24-HYDROXYLATED VITAMIN D COMPOUNDS AND USES THEREOF
    Publication number: 20120180142
    Abstract: The instant invention relates to the use of 24-hydroxylated vitamin D compounds as therapeutics in mammalian bone fracture repair. In addition, the instant invention relates to novel 24-hydroxylated vitamin D compound receptors which can be employed in the development of compounds capable of facilitating fracture repair in animals. The instant invention also relates to nucleic acids encoding such receptors as well as vectors, host cells, transgenic animals comprising such nucleic acids and screening assays employing such receptors.
    Type: Application
    Filed: November 29, 2011
    Publication date: July 12, 2012
    Applicant: Shriners Hospital For Children
    Inventor: Rene St-Arnaud
  • FIAT nucleic acids and proteins and uses thereof
    Patent number: 8062851
    Abstract: The invention provides FIAT nucleic acids and proteins, and methods of using such nucleic acids and proteins.
    Type: Grant
    Filed: August 19, 2008
    Date of Patent: November 22, 2011
    Assignee: Shriners Hospitals for Children
    Inventor: René St-Arnaud
  • FIAT NUCLEIC ACIDS AND PROTEINS AND USES THEREOF
    Publication number: 20100136528
    Abstract: The invention provides FIAT nucleic acids and proteins, and methods of using such nucleic acids and proteins.
    Type: Application
    Filed: August 19, 2008
    Publication date: June 3, 2010
    Applicant: SHRINERS HOSPITALS FOR CHILDREN, a Colorado corporation
    Inventor: Rene St-Arnaud
  • FIAT nucleic acids and proteins and uses thereof
    Patent number: 7414109
    Abstract: The invention provides FIAT nucleic acids and proteins, and methods of using such nucleic acids and proteins.
    Type: Grant
    Filed: April 29, 2005
    Date of Patent: August 19, 2008
    Assignee: Shriners Hospital for Children
    Inventor: René St-Arnaud
  • FIAT nucleic acids and proteins and uses thereof
    Publication number: 20050278796
    Abstract: The invention provides FIAT nucleic acids and proteins, and methods of using such nucleic acids and proteins.
    Type: Application
    Filed: April 29, 2005
    Publication date: December 15, 2005
    Inventor: Rene St-Arnaud
  • Calreticulin-deficient cells
    Patent number: 6461865
    Abstract: The invention relates to calreticulin-deficient cells. The cells can be either homozygous or heterozygous for the calreticulin mutation.
    Type: Grant
    Filed: April 23, 1998
    Date of Patent: October 8, 2002
    Inventors: Shoukat Dedhar, Rene St-Arnaud
  • 1-.alpha.-hydroxylase materials and methods
    Patent number: 6096876
    Abstract: The invention is directed to polynucleotides encoding all or a fragment of the P450 moiety of vitamin D1 .alpha.-Hydrdoxylase and polypeptides encoded thereby. It encompasses antibodies to the polynucleotides and hybridizing polynucleotides. The polynucleotides and polypeptides are used in methods of diagnosing and treating vitamin D-related disorders and of producing vitamin D metabolites. The invention also encompasses expression vectors and animal cells comprising the polynucleotides.
    Type: Grant
    Filed: August 6, 1997
    Date of Patent: August 1, 2000
    Assignee: Shriners Hospitals for Children
    Inventors: Rene St-Arnaud, Francis H. Glorieux